Patents by Inventor Melinda Gunnell

Melinda Gunnell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hapten compounds and compositions and uses thereof
    Patent number: 8853146
    Abstract: The invention generally relates to hapten compounds comprising either (+)methamphetamine or (+)amphetamine conjugated to a linker. Generally speaking, hapten compounds of the invention may be used to elicit an immune response to one or more of (+)methamphetamine, (+)amphetamine, or (+)MDMA.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: October 7, 2014
    Assignee: The Board of Trustees of the University of Arkansas
    Inventors: S. Michael Owens, Melinda Gunnell, F. Ivy Carroll
  • Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds
    Patent number: 7858756
    Abstract: The invention generally relates to monoclonal antibodies that recognize at least one compound from the group consisting of (+) methamphetamine, (+) amphetamine, and (+) 3,4-methylenedioxymethamphetamine ((+) MDMA). Generally speaking, the monoclonal antibodies do not recognize (?) methamphetamine, (?) amphetamine, or (?) MDMA.
    Type: Grant
    Filed: June 15, 2007
    Date of Patent: December 28, 2010
    Assignee: The Board of Trustees of the University of Arkansas
    Inventors: S. Michael Owens, Melinda Gunnell, Yingni Chi, F. Ivy Carroll, Ralph Henry, Eric Peterson
  • HAPTEN COMPOUNDS AND COMPOSITIONS AND USES THEREOF
    Publication number: 20100143391
    Abstract: The invention generally relates to hapten compounds comprising either (+)methamphetamine or (+)amphetamine conjugated to a linker. Generally speaking, hapten compounds of the invention may be used to elicit an immune response to one or more of (+)methamphetamine, (+)amphetamine, or (+)MDMA.
    Type: Application
    Filed: April 18, 2008
    Publication date: June 10, 2010
    Applicant: The Board of Trustees of the University of Arkansas
    Inventors: S. Michael Owens, Melinda Gunnell, F. Ivy Carroll
  • MONOCLONAL ANTIBODIES THAT SELECTIVELY RECOGNIZE METHAMPHETAMINE AND METHAMPHETAMINE LIKE COMPOUNDS
    Publication number: 20080125579
    Abstract: The invention generally relates to monoclonal antibodies that recognize at least one compound from the group consisting of (+) methamphetamine, (+) amphetamine, and (+) 3,4-methylenedioxymethamphetamine ((+) MDMA). Generally speaking, the monoclonal antibodies do not recognize (?) methamphetamine, (?) amphetamine, or (?) MDMA.
    Type: Application
    Filed: June 15, 2007
    Publication date: May 29, 2008
    Applicant: Board of Trustees of the University of Arkansas
    Inventors: S. Michael Owens, Melinda Gunnell, Yingni Chi, F. Ivy Carroll, Ralph Henry, Eric Peterson
  • Antibodies against drugs of abuse
    Publication number: 20050013809
    Abstract: The present invention is related to antibodies directed to various drugs of abuse and uses of such antibodies. In preferred embodiments, the drugs of abuse are amphetamine, methamphetamine, or phencyclidine (PCP). In particular, in accordance with the present invention, there are provided fully man monoclonal antibodies directed to drugs of abuse. Nucelotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR3 or CDR1 through CDR3, are provided. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also provided.
    Type: Application
    Filed: December 2, 2003
    Publication date: January 20, 2005
    Inventors: Samuel Owens, Frank Carroll, Philip Abraham, Melinda Gunnell, Mary Haak-Frendscho, Xiao Feng